Tropic Virus Prediction Is Associated with a Nadir CD 4 T-Cell Count below 100 Cells / mm 3

Objective: The aim of this study was to evaluate tropism prediction performances of three algorithms [geno2pheno false-positive rate 10% (G2P10), position-specific scoring matrix (PSSM) and a combination of the 11/25 and net charge rules] and to investigate the viral and host factors potentially involved in the X4 or R5 prediction in human immunodeficiency virus-1 (HIV-1) patients. Methods: Viral tropism was determined in 179 HIV-1-infected patients eligible for CCR5 antagonist therapy. HIV-1 RNA or DNA was extracted and amplified for env gp120 sequencing. In parallel, demographic, viral, immunological and clinical determinants were analyzed. Results: According to the G2P10 algorithm, 48 patients harbored X4 or X4R5 virus. The tropism prediction was concordant for 87.7 and 88.2% of samples when comparing G2P10 with PSSM or with a combination of the 11/25 and net Received: September 10, 2014 Accepted after revision: April 9, 2015 Published online: May 21, 2015 Sandrine Castelain Laboratoire de Virologie, Centre de Biologie Humaine CHU Hôpital Sud FR–80054 Amiens Cedex (France) E-Mail sandrine.castelain @ u-picardie.fr © 2015 S. Karger AG, Basel 0300–5526/15/0583–0155$39.50/0

[1]  Simon A. A. Travers,et al.  The Influence of N-Linked Glycans on the Molecular Dynamics of the HIV-1 gp120 V3 Loop , 2013, PloS one.

[2]  L. Scudeller,et al.  X4 viruses are frequently archived in patients with long-term HIV infection but do not seem to influence the “inflamm-aging” process , 2013, BMC Infectious Diseases.

[3]  V. Calvez,et al.  Natural evolution of CD4+ cell count in patients with CD4 >350 or >500 cells/mm3 at the time of diagnosis according to HIV‐1 coreceptor tropism , 2012, Journal of Medical Virology.

[4]  L. Stuyver,et al.  Comparison of phenotypic and genotypic tropism determination in triple-class-experienced HIV patients eligible for maraviroc treatment , 2010, The Journal of antimicrobial chemotherapy.

[5]  R. Paredes,et al.  Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists. , 2010, AIDS reviews.

[6]  J. Kostman,et al.  Relationship Between HIV Coreceptor Tropism and Disease Progression in Persons With Untreated Chronic HIV Infection , 2009, Journal of acquired immune deficiency syndromes.

[7]  Paolo Piazza,et al.  Emergence and persistence of CXCR4-tropic HIV-1 in a population of men from the multicenter AIDS cohort study. , 2008, The Journal of infectious diseases.

[8]  V. Calvez,et al.  Comparison of two genotypic algorithms to determine HIV‐1 tropism * , 2008, HIV medicine.

[9]  L. Ruiz,et al.  Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance. , 2007, The Journal of antimicrobial chemotherapy.

[10]  John P. Moore,et al.  The CCR5 and CXCR4 coreceptors--central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. , 2004, AIDS research and human retroviruses.

[11]  K. Peden,et al.  HIV coreceptors: role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors. , 2003, Biochimica et biophysica acta.

[12]  M. Dittmar,et al.  The N-linked glycan g15 within the V3 loop of the HIV-1 external glycoprotein gp120 affects coreceptor usage, cellular tropism, and neutralization. , 2002, Virology.

[13]  Jaap Goudsmit,et al.  N-Linked Glycosylation of the HIV Type-1 gp120 Envelope Glycoprotein as a Major Determinant of CCR5 and CXCR4 Coreceptor Utilization* , 2001, The Journal of Biological Chemistry.

[14]  E. Poveda,et al.  Design and validation of new genotypic tools for easy and reliable estimation of HIV tropism before using CCR 5 antagonists , 2009 .